Novozymes A/S (CPH:NSIS.B)
Denmark · Delayed Price · Currency is DKK 387.00
+0.60 (0.16%)
Jun 12, 2026, 4:59 PM CET
Novozymes Ratios and Metrics
Market cap in millions DKK. Fiscal year is January - December.
Millions DKK. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 12, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 180,309 | 190,009 | 114,098 | 102,903 | 97,339 | 148,811 | |
Market Cap Growth | -16.52% | 66.53% | 10.88% | 5.72% | -34.59% | 52.88% |
Enterprise Value | 201,872 | 210,401 | 125,411 | 109,953 | 103,638 | 154,415 |
Last Close Price | 387.00 | 407.82 | 407.73 | 371.07 | 351.91 | 537.02 |
PE Ratio | 40.49 | 43.68 | 81.60 | 34.04 | 26.68 | 47.83 |
Forward PE | 23.71 | 26.35 | 30.19 | 26.86 | 28.58 | 45.11 |
PEG Ratio | 3.42 | 2.42 | 3.10 | 4.26 | 4.10 | 10.95 |
PS Ratio | 5.74 | 6.12 | 3.99 | 5.74 | 5.55 | 9.95 |
PB Ratio | 2.21 | 2.34 | 1.37 | 7.35 | 7.03 | 12.58 |
P/TBV Ratio | 16.52 | 17.57 | 16.77 | 54.97 | 52.83 | 94.61 |
P/FCF Ratio | 28.76 | 31.34 | 22.45 | 44.75 | 78.12 | 49.75 |
P/OCF Ratio | 18.82 | 20.83 | 15.00 | 24.74 | 24.30 | 36.64 |
EV/Sales Ratio | 6.43 | 6.78 | 4.39 | 6.13 | 5.90 | 10.33 |
EV/EBITDA Ratio | 17.53 | 19.93 | 15.31 | 20.45 | 22.72 | 38.54 |
EV/EBIT Ratio | 28.34 | 34.49 | 33.56 | 27.60 | 22.72 | 38.54 |
EV/FCF Ratio | 32.20 | 34.70 | 24.67 | 47.81 | 83.18 | 51.63 |
Debt / Equity Ratio | - | 0 | 0 | 0 | 0.03 | 0.51 |
Debt / EBITDA Ratio | 3.93 | 2.13 | 1.64 | 1.45 | 1.52 | 1.54 |
Debt / FCF Ratio | 3.83 | 3.70 | 2.64 | 3.39 | 5.58 | 2.07 |
Net Debt / Equity Ratio | 0.26 | 0.25 | 0.14 | 0.48 | 0.43 | 0.44 |
Net Debt / EBITDA Ratio | 3.53 | 1.93 | 1.38 | 1.24 | 1.30 | 1.30 |
Net Debt / FCF Ratio | 3.44 | 3.36 | 2.23 | 2.90 | 4.74 | 1.75 |
Asset Turnover | 0.26 | 0.26 | 0.40 | 0.64 | 0.66 | 0.66 |
Inventory Turnover | 2.45 | 2.57 | 3.35 | 2.20 | 2.35 | 2.36 |
Quick Ratio | 1.03 | 0.44 | 1.06 | 0.76 | 0.77 | 0.84 |
Current Ratio | 1.67 | 0.72 | 1.72 | 1.26 | 1.33 | 1.38 |
Return on Equity (ROE) | 5.48% | 5.30% | 4.67% | 21.27% | 27.86% | 26.79% |
Return on Assets (ROA) | 3.93% | 4.06% | 3.87% | 10.97% | 13.98% | 14.17% |
Return on Invested Capital (ROIC) | 3.97% | 4.11% | 4.10% | 12.19% | 15.98% | 16.80% |
Return on Capital Employed (ROCE) | 5.66% | 5.89% | 5.91% | 18.86% | 22.72% | 22.59% |
Earnings Yield | 2.47% | 2.29% | 1.23% | 2.94% | 3.75% | 2.09% |
FCF Yield | 3.48% | 3.19% | 4.46% | 2.23% | 1.28% | 2.01% |
Dividend Yield | 1.68% | 1.58% | 1.00% | 2.78% | 1.57% | 0.98% |
Payout Ratio | 111.92% | 69.00% | 81.69% | 94.41% | 41.49% | 46.60% |
Buyback Yield / Dilution | -60.87% | -1.73% | -65.40% | 0.31% | 0.52% | 0.65% |
Total Shareholder Return | -59.18% | -0.15% | -64.40% | 3.09% | 2.09% | 1.63% |